SD-809
SD-809-C-23
Phase 3 small_molecule completed
Quick answer
SD-809 for Tardive Dyskinesia is a Phase 3 program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 3 ClinicalTrials.gov record(s).
Program details
- Company
- TEVA PHARMACEUTICAL INDUSTRIES LTD
- Indication
- Tardive Dyskinesia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed